Literature DB >> 19880774

Hypercoagulability and thrombotic complications in hemolytic anemias.

Kenneth I Ataga.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19880774      PMCID： PMC2770956          DOI： 10.3324/haematol.2009.013672

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  38 in total

1.  Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria.

Authors:  Jan Simak; Karel Holada; Antonio M Risitano; Jan H Zivny; Neal S Young; Jaroslav G Vostal
Journal:  Br J Haematol       Date:  2004-06       Impact factor: 6.998

2.  Hemoglobin Duarte: (alpha2beta2 62(E6)Ala leads to Pro): a new unstable hemoglobin with increased oxygen affinity.

Authors:  E Beutler; A Lang; H Lehmann
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

3.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

4.  Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

5.  Pulmonary thrombotic arteriopathy in patients with sickle cell disease.

Authors:  M O Adedeji; J Cespedes; K Allen; C Subramony; M D Hughson
Journal:  Arch Pathol Lab Med       Date:  2001-11       Impact factor: 5.534

6.  Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation.

Authors:  B N Setty; S Kulkarni; A K Rao; M J Stuart
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

7.  Thrombogenesis in sickle cell disease.

Authors:  A Tomer; L A Harker; S Kasey; J R Eckman
Journal:  J Lab Clin Med       Date:  2001-06

8.  Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells.

Authors:  N J Wandersee; J C Lee; S A Deveau; J E Barker
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

9.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

Authors:  V A Fadok; D R Voelker; P A Campbell; J J Cohen; D L Bratton; P M Henson
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

10.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

Authors:  Arun S Shet; Omer Aras; Kalpna Gupta; Mathew J Hass; Douglas J Rausch; Nabil Saba; Louann Koopmeiners; Nigel S Key; Robert P Hebbel
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113
View more
  60 in total

Review 1.  Hypercoagulability in congenital haemolytic anaemias.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2012-10-25       Impact factor: 3.443

2.  Paroxysmal nocturnal hemoglobinuria and eculizumab.

Authors:  Lucio Luzzatto; Antonio Maria Risitano; Rosario Notaro
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

Review 3.  Microparticles in stored red blood cells: submicron clotting bombs?

Authors:  Olivier Rubin; David Crettaz; Jean-Daniel Tissot; Niels Lion
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

4.  Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke.

Authors:  Candice M Brown; Cheryl D Bushnell; Gregory P Samsa; Larry B Goldstein; Carol A Colton
Journal:  Transl Stroke Res       Date:  2015-09-15       Impact factor: 6.829

5.  Impact of microparticles derived from erythrocytes on fibrinolysis.

Authors:  Grigory Levin; Ekaterina Sukhareva; Athina Lavrentieva
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

Review 6.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

7.  Recurrent nonbacterial thrombotic endocarditis: A novel therapeutic approach.

Authors:  Michael A Brock; Mark S Bleiweis; Jana Reid; Diego Moguillanksy
Journal:  J Cardiol Cases       Date:  2018-02-17

8.  Investigation of the Etiology of Anemia in Thromboangiitis Obliterans.

Authors:  Mohammad Mehdi Akbarin; Hassan Ravari; Ataollah Rajabnejad; Narges Valizadeh; Bahare Fazeli
Journal:  Int J Angiol       Date:  2016-01-12

9.  Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

Authors:  Dominique Helley; Régis Peffault de Latour; Raphaël Porcher; Celso Arrais Rodrigues; Isabelle Galy-Fauroux; Jeanne Matheron; Arnaud Duval; Jean-François Schved; Anne-Marie Fischer; Gérard Socié
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

10.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.